Track cycle timing, bleeding, pelvic pain, discharge, pregnancy context, urinary symptoms, test results, medicines, and clinician instructions.
Condition detail
Breast Cancer
Breast Cancer is a reproductive, pregnancy, breast, prostate, or sexual-health condition tracked with cycle or pregnancy context, pain, bleeding, discharge, urinary symptoms, test results, medicines, and urgent-care guidance when relevant.
Connected records
Database matches for this condition
Erectile dysfunction
Erectile dysfunction is a urinary, pelvic, breast, menstrual, or reproductive symptom that may be tracked with timing, pain, bleeding, discharge, and fluid intake.
Frequent urination
Frequent urination is a urinary, pelvic, breast, menstrual, or reproductive symptom that may be tracked with timing, pain, bleeding, discharge, and fluid intake.
Heavy menstrual bleeding
Heavy menstrual bleeding is a urinary, pelvic, breast, menstrual, or reproductive symptom that may be tracked with timing, pain, bleeding, discharge, and fluid intake.
Hot flashes
Hot flashes is a urinary, pelvic, breast, menstrual, or reproductive symptom that may be tracked with timing, pain, bleeding, discharge, and fluid intake.
Nighttime urination
Nighttime urination is a urinary, pelvic, breast, menstrual, or reproductive symptom that may be tracked with timing, pain, bleeding, discharge, and fluid intake.
Urgent urination
Urgent urination is a urinary, pelvic, breast, menstrual, or reproductive symptom that may be tracked with timing, pain, bleeding, discharge, and fluid intake.
Urinary incontinence
Urinary incontinence is a urinary, pelvic, breast, menstrual, or reproductive symptom that may be tracked with timing, pain, bleeding, discharge, and fluid intake.
Urinary retention
Urinary retention is a urinary, pelvic, breast, menstrual, or reproductive symptom that may be tracked with timing, pain, bleeding, discharge, and fluid intake.
Anastrozole
Used for: Anastrozole is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer ( 1.1 ) First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer ( 1.2 ) Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy.
Docetaxel anhydrous
Used for: Docetaxel Injection is a microtubule inhibitor indicated for: • Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC ( 1.1 ) • Non-small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure.
Doxorubicin hydrochloride
Used for: Doxorubicin Hydrochloride Injection is an anthracycline topoisomerase inhibitor indicated: • as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer ( 1.1 ) • for the treatment of: acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms' tumor, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas.
Everolimus
Used for: 1. INDICATIONS AND USAGE Everolimus tablets are a kinase inhibitor indicated for the treatment of: Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole.
Fulvestrant
Used for: Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of: Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy. ( 1 ) HR-positive advanced breast cancer in postmenopausal women with disease progression following endocrine therapy.